September 2020

Leaders in the field provide an overview of the DOAC drug class and how best to use the growing number of options.

Institutions should consider optimal targets, testing volumes, and notification and reporting practices when making their choice.

Pharmacists can play an integral role in collaborating with physicians to manage patient therapy.

Conduct proper review and evaluation of ARV and DOAC pharmacokinetics and metabolism prior to recommending treatment.

Proposed CMS changes could hurt many health systems that are already struggling due to COVID-19 pandemic.

Study also highlights transitions-of-care programs that help patients avoid ED visits or acute care stays.

Maximizer programs are likely to lead to the dwindling or death of PAPs as we know them.

Asembia is the industry’s leading group purchasing organization (GPO) focused on the specialty pharmacy market.

As we head into flu season, count on Directions in Health-System Pharmacy™ to continue to report on the latest developments on COVID-19.